Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
Summary
Repligen announced a strategic partnership with Novasign to integrate Novasign’s machine learning and modeling workflow into Repligen’s filtration systems. Repligen also plans to invest in Novasign to support scale-up and expansion. The collaboration aims to improve bioprocess digitalization, add digital twin capabilities, and speed process development for biopharmaceutical customers. The companies expect the combined solution to strengthen real-time predictive control, lower development costs, and improve scale-up efficiency.
Classifications
industries
No industries detected
applications
Business Intelligence
AskAI Classifications
Labels
SaaS
Engineering Software
Data Science Platforms
Linked Companies
Novasign
$1M to $5M